Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study

Our previous study reported the favorable short-term outcome and good tolerance of integrating oxaliplatin into capecitabine-based (XELOX regimen) preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC). The present study reported the long-term oncological outcome of this phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianhong, Lin, Junzhong, Zeng, Zhifan, Wu, Xiaojun, Chen, Gong, Li, Liren, Lu, Zhenhai, Ding, Peirong, Wan, Desen, Pan, Zhizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649637/
https://www.ncbi.nlm.nih.gov/pubmed/29085451
http://dx.doi.org/10.3892/ol.2017.6764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649637/
https://www.ncbi.nlm.nih.gov/pubmed/29085451
http://dx.doi.org/10.3892/ol.2017.6764

Ejemplares similares